Home/Filings/4/0000899243-23-009094
4//SEC Filing

Young Richard A 4

Accession 0000899243-23-009094

CIK 0001850838other

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 4:05 PM ET

Size

4.8 KB

Accession

0000899243-23-009094

Insider Transaction Report

Form 4
Period: 2023-03-17
Young Richard A
Director10% Owner
Transactions
  • Sale

    Common Stock

    2023-03-17$8.00/sh10,000$80,000754,118 total
Footnotes (1)
  • [F1]The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022.

Issuer

Omega Therapeutics, Inc.

CIK 0001850838

Entity typeother

Related Parties

1
  • filerCIK 0001490283

Filing Metadata

Form type
4
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:05 PM ET
Size
4.8 KB